CLINICAL_TRIALS
trial_result
· 2018-07-17
Clinical Trial Update: Cold Contact Urticaria Treatment With Rilonacept [Phase 2]
Summary
Phase 2 trial evaluating rilonacept for cold contact urticaria has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Charite University, Berlin, Germany | Conditions: Cold Contact Urticaria | Phase 2 | Status: COMPLETED